Gene Therapy Trials Show Positive Results in Sickle Cell Disease and Thalassemia
Results from two early-phase trials suggest that CRISPR-Cas12a gene editing has the potential to cure sickle cell disease and transfusion-dependent beta-thalassemia.
Results from two early-phase trials suggest that CRISPR-Cas12a gene editing has the potential to cure sickle cell disease and transfusion-dependent beta-thalassemia.
ACD supports the generation of memory precursor CD8+ T cells upon strong activation. Barandun et al. show that the mother centrosome is predominantly inherited by the effector-like…
Scientists are exploring using earpiece microphones, also known as hearables, to detect and ‘listen’ to early signs of Alzheimer’s as a noninvasive test.
The NHS will never work properly unless the government acts on social care, writes Richard Humphries After six months in power, the UK government has…
The rapid spread of artemisinin partial resistance (ART-R) across east Africa, the Horn of Africa, and southern Africa threatens to undermine malaria control and elimination…
AlphaFold solved a structural biology riddle: predicting protein structure. And yet, CASP, a global competition born to solve that problem, lives on.
Discover Samsung’s adorable robotic ball-butler, Ballie. Learn about its features and its upcoming launch at CES 2025.
Cleveland Clinic Cancer Institute is conducting a clinical trial to demonstrate whether early interventions with prehabilitation can improve outcomes and quality of life for senior…
bioRxiv – the preprint server for biology, operated by Cold Spring Harbor Laboratory, a research and educational institution
bioRxiv – the preprint server for biology, operated by Cold Spring Harbor Laboratory, a research and educational institution
Objectives To investigate clinical characteristics, symptom profile, testing practices, treatment patterns and quality of life (QoL) among patients with pulmonary arterial hypertension (PAH) in Latin…